Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort ascending PI Organization Title Grant Number Initiative Program Official
Barber, Glen N.

Ohio State University
United States

Development of A HTLV-1 Vaccine 7R01CA252049-05 Marjorie Perloff, M.D.
Bao, Ting

Dana-Farber Cancer Inst
United States

Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial 5R01CA251470-06 Goli Samimi, Ph.D., M.P.H.
Banerjee, Imon

Mayo Clinic Arizona
United States

Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer 5R01CA289249-02 Nicholas Hodges, Ph.D.
Balu, Mihaela

University Of California-Irvine
United States

Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma 4R01CA259019-04 PAR-20-155 (R01 Clinical Trial Optional) Guillermo Marquez, Ph.D.
Balskus, Emily Patricia

Harvard University
United States

PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 3OT2CA297577-01S1 Asad Umar, D.V.M., Ph.D.
Balaj, Leonora

Massachusetts General Hospital
United States

Standardized Molecular Analyses of Glioma EVs 5R01CA237500-05 Matthew Young, Ph.D.
Baghdadi, Tareq Al

Saint Joseph Mercy Health System
United States

Michigan Cancer Research Consortium NCORP 3UG1CA189971-11S1 Vanessa A. White, M.P.H.
Badve, Sunil S.

Emory University
United States

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms 5R01CA281932-02 Wendy Wang, Ph.D., M.Sc.
Backman, Vadim

Northwestern University At Chicago
United States

Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification 1R01CA289294-01A1 Claire Zhu, Ph.D.
Atigadda, Venkatram Reddy

University Of Alabama At Birmingham
United States

Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer 5R01CA276683-03